Navigation Links
The Boston Eye Group Implants First Intraocular Pressure Transducer for Glaucoma Monitoring
Date:1/25/2013

Brookline, MA (PRWEB) January 25, 2013

Glaucoma is characterized by slow, painless loss of vision due to optic nerve damage mostly related to an elevated eye pressure. Until now, doctors have relied on in-office methods to measure the eye pressure.This requires a visit to the doctor’s office every few weeks to few months. A new surgically implanted device may for the first time allow home monitoring of eye pressure.Once inside the eye, it relays measurements to a remote-held reader wirelessly.

Following years of animal research, Samir Melki MD PhD of Harvard Medical School and the Boston Eye Group implanted the device for the first time in a patient with Glaucoma during cataract surgery. “This may be a game-changer when it comes to glaucoma management” said Dr. Melki. “ It should allow us to understand the disease through a tremendous ability to collect pressure data”

The wireless intraocular pressure transducerwas developed by Implandata GmbH (Hannover, Germany). It integrates pressure sensors, temperature sensor, identification encoder, analog-to-digital encoder, and telemetry unit into a single microelectromechanical system-application specific integrated circuit (MEMS-ASIC). This digital ultra-miniature system employs complementary metal oxide semiconductor (CMOS) technology for its electronic components. The electronic components are either biocompatible or inert. The ASIC is attached to a circular microcoil antenna made of gold and both of these components are hermetically encapsulated in platinum-cured silicone. This biocompatible silicone material makes up the entire surface of the implant. The implant itself is designed to remain in-vivo indefinitely. The outside diameter of the transponder disc is only 11.3 mm, inside diameter is 7 mm, its thickness is 0.9 mm and the weight is 0.1 g.

“The device seems to be very well tolerated in the eye” said Melki, who implanted the device 18months ago at the Beirut Eye Specialist Hospital. “Although more studies need to be conducted, we have seen no side effects until now”.

There are several benefits to the novelmethod.It allows IOP measurements wirelessly through radiofrequency whichoffers the prospect of lifelong frequent eye pressure monitoring. It may reduce the number of doctors’ visits and provide measurements at times that were inaccessible previously such as during sleep. This may allow glaucoma specialists to understand why certain patients still lose vision despite seemingly low pressures. The device is not FDA-approved at this time.

For more information, contact Rick Young at Rick(at)bostoneyegroup(dot)com or Max Ostermeier at mostermeier(at)implandata(dot)com. You can also visit http://www.bostoneyegroup.com or call 617-566-0062.

Read the full story at http://www.prweb.com/releases/2013/1/prweb10354744.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Linguists to gather in Boston for National Conference
2. Northofbostonusa.com Will Release its N5 Fashion Shoes Next Monday
3. Boston College researcher looks to stop a deadly parasite in its tracks
4. Boston Medical Center awarded elite distinction as a 2012 Leapfrog Top Hospital
5. Cincinnati and Boston Childrens Hospitals receive an NIH Autism Center of Excellence Grant
6. Boston University researchers expand synthetic biologys toolkit
7. Snoring Isn’t Sexy Member, Dr. Mark Levy attends the American Academy of Dental Sleep Medicine Meeting in Boston, MA
8. SLEEP 2012 presents latest in sleep medicine and research June 11-13 in Boston
9. Boston researcher, surgical oncologist receives national award
10. Leaders in childrens health to gather in Boston
11. US Drug Watchdog Now Urges Users of Yaz Yasmin Birth Control Pills That Had a Stroke Or Developed Other Serious Medical Conditions to Contact The Johnson Law Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... Mirixa Corporation ... adherence, and other pharmacist-delivered patient care services, has announced the promotions of Karen ... to vice president of sales. , Litsinger joined Mirixa in 2008 after ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... David ... with global law firm Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, ... of the DeviceTalks series, and attorneys from the firm’s global Life Sciences & Medical ...
(Date:12/8/2016)... ... December 08, 2016 , ... Launching ... innovative Unified Instance Manager architecture, meeting the needs of multichannel growth and ... the unattended auto-dialing system without agents, Presence Robodialer, provides greater operational capacity, ...
(Date:12/8/2016)... ... December 08, 2016 , ... STAT courier is pleased to announce that ... for Texas, they are expanding their presence in Dallas. One of the most exciting ... bring new jobs to the Dallas and Forth Worth market. STAT takes pride in ...
(Date:12/8/2016)... ... December 08, 2016 , ... Healthcare is ... Dr. Botelho advocates for the mass media launching of story movements to highlight ... to share their unfortunate experiences; such a movement can generate the network power ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... Dec. 8, 2016 Australia Glaucoma Surgery ... GlobalData,s new report, "Australia Glaucoma Surgery Devices Market ... the Australia Glaucoma Surgery Devices market. The report ... (in units) and average prices (USD) within market ... also provides company shares and distribution shares data ...
(Date:12/8/2016)... KEY FINDINGS The global medical lifting sling ... for growth of the medical lifting sling market are ... high recovery cost of injuries and government initiatives to ... refers to an assistive device that helps caregiver transfer ... the lift and hold the patient. It is important ...
(Date:12/8/2016)... INDIANAPOLIS , Dec. 8, 2016  Eli Lilly ... detailed results of its phase 3 EXPEDITION3 trial at ... (CTAD) meeting. As previously disclosed, solanezumab did not meet ... study of solanezumab initiated in people with mild dementia ... pursue regulatory submissions for solanezumab for the treatment of ...
Breaking Medicine Technology: